Biovariance GmbH was founded in 2013 and is headquartered in Waldsassen, Germany. Its multidisciplinary team develops innovative AI solutions for precision medicine in the healthcare, pharma and biotech sectors. In cooperation with physicians, BioVariance offers long-term monitoring of molecular changes in patients to predict the effectiveness, side effects and drug interaction, thereby helping determine optimal medication and dosage. To achieve this, state-of-the-art automatization and parallelization techniques, machine learning, and mathematical algorithms are combined to analyze complex biomedical data.